Which Z‑drug is the safest for long‑term use in an adult without significant liver disease or a history of substance abuse?

Eszopiclone is the safest Z-drug for long-term use among the three available options

For an adult without significant liver disease or substance abuse history requiring long-term hypnotic therapy, eszopiclone is the preferred Z-drug choice, as it provides both sleep onset and maintenance benefits and has demonstrated the most favorable long-term safety profile among Z-drugs.

Evidence-Based Rationale

The 2017 American Academy of Sleep Medicine guidelines provide weak recommendations for all three Z-drugs (eszopiclone, zolpidem, and zaleplon), but with important distinctions 1:

Z-Drug Comparison

Eszopiclone (2-3 mg):

• Addresses both sleep onset AND sleep maintenance insomnia
• Has demonstrated efficacy without rapid tolerance development
• Shows low abuse potential in long-term studies 2

Zolpidem (10 mg):

• Also treats both sleep onset and maintenance
• However, carries higher misuse/abuse and withdrawal risk compared to other Z-drugs 3
• More frequently involved in adverse drug reactions in European pharmacovigilance data

Zaleplon (10 mg):

• Only effective for sleep onset insomnia (not maintenance)
• Limited long-term data available
• Narrower therapeutic application

Critical Safety Considerations for Long-Term Use

Falls and Fractures Risk

All Z-drugs significantly increase fall and fracture risk in observational studies, particularly with prolonged use 4. This risk appears consistent across the class and should be discussed with patients regardless of which agent is chosen.

Cognitive Concerns

Recent meta-analyses suggest Z-drugs may be associated with increased Alzheimer's disease risk (OR 1.14 for Z-drugs specifically), though causality remains uncertain 5. Short-acting agents showed higher associations than broad-acting benzodiazepines.

Dependence Potential

While originally marketed as safer alternatives to benzodiazepines, Z-drugs do carry dependence risk 3, 6:

• Approximately 16.8% of new users become long-term recurrent users 6
• Co-medication with benzodiazepines or opioids is common (27.9% and 33.9% respectively in long-term users)
• Zolpidem shows the highest misuse/abuse profile among Z-drugs

Practical Prescribing Algorithm

When Z-drug therapy is deemed necessary:

1. First-line choice: Eszopiclone 2-3 mg

   • Broadest indication (onset + maintenance)
   • Lower abuse signal than zolpidem
   • Better long-term tolerance data

2. If only sleep onset is problematic: Consider zaleplon 10 mg

   • Shortest half-life
   • May reduce next-day effects
   • But limited long-term safety data

3. Avoid zolpidem for long-term use when alternatives exist

   • Highest misuse/withdrawal risk among Z-drugs 3

4. Monitor closely:

   • Reassess need every 3-6 months
   • Screen for falls, cognitive changes
   • Check for dose escalation or co-medication with other CNS depressants

Important Caveats

"Long-term use" itself is problematic: All guidelines emphasize that hypnotics should ideally be used short-term (≤4 weeks) 6. The question of which Z-drug is "safest" for long-term use is somewhat paradoxical, as none are truly safe for extended use.

The real answer may be "none of the above": If truly long-term pharmacotherapy is required, consider:

• Low-dose doxepin (3-6 mg) for maintenance insomnia 1
• Cognitive behavioral therapy for insomnia (CBT-I) as first-line
• Addressing underlying causes of chronic insomnia

Age matters: In patients ≥65 years, the fall/fracture risk becomes even more clinically significant 4, and the risk-benefit calculation may favor non-pharmacological approaches or alternative agents like low-dose doxepin.

The evidence quality for long-term Z-drug safety is generally low to moderate 4, 5, reflecting the reality that these medications were never adequately studied for the chronic use patterns commonly seen in clinical practice.